PolyPeptide Group AG
ISIN
CH1110760852
Ticker
PPGN
Sector
Sub-Industry
Country
Switzerland
Year Founded
ISIN
CH1110760852
Ticker
PPGN
Sector
Sub-Industry
Country
Switzerland
Year Founded
PolyPeptide Group is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Dating back to 1952, PolyPeptide today manufactures around one-half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with around 1,100 employees at the end of 2021, its diversity brings breadth, depth of knowledge and experience to the group.
PolyPeptide has grown organically and by selective acquisition of existing expertise, culminating in its position today as a leader in outsourced peptide manufacturing.
1,100
Worldwide
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 11.04.2024 | None | Non-Executive member | Buy | CHF 75,000.00 |
| 11.04.2024 | None | Non-Executive member | Buy | CHF 72,000.00 |
| 11.04.2024 | None | Non-Executive member | Buy | CHF 50,000.00 |
| 11.04.2024 | None | Non-Executive member | Buy | CHF 35,000.00 |
| 10.11.2023 | None | Executive member | Buy | CHF 51,250.00 |
| 11.10.2023 | None | Executive member | Buy | CHF 2,876,348.62 |
| 10.10.2023 | None | Executive member | Buy | CHF 371,202.96 |
| 26.04.2022 | None | Non-Executive member | Buy | CHF 90,000.00 |
| 26.04.2022 | None | Non-Executive member | Buy | CHF 70,000.00 |
| 26.04.2022 | None | Non-Executive member | Buy | CHF 50,000.00 |
CH1110760852
5067007JCKTPOX4G9758
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.